Post your clinical trial on JoinClinicalTrials.com to reach thousands of viewer daily. Our Clinical Trial Listings have consistently proven to be an ...
Conditions: Alcohol Use Disorder; Substance Use Disorders Interventions: Other: Measurement; Other: Feedback Sponsors: University of Washington; National Institute on Alcohol Abuse and Alcoholism (NIAAA) Recruiting
Conditions: High Risk Hematological Malignancy; Cord Blood Transplant Intervention: Biological: ECT-001-CB (UM171-Expanded Cord Blood Transplant) Sponsors: ExCellThera inc.; Fred Hutchinson Cancer Research Center Recruiting
Conditions: Pain; BPH With Urinary Obstruction; BPH With Urinary Obstruction With Other Lower Urinary Tract Symptoms Interventions: Drug: Ibuprofen 600 mg; Behavioral: Education Sponsors: Benaroya Research Institute; Virginia Mason Hospital/Medical Center Recruiting
Condition: Diverticulitis Interventions: Procedure: Partial Colectomy; Other: Medical Management Sponsors: University of Washington; Patient-Centered Outcomes Research Institute Recruiting
Conditions: Amputation; Artificial Limb Interventions: Device: Crossover foot; Device: Energy Storing Foot Sponsor: University of Washington Recruiting
Condition: Opioid-use Disorder Intervention: Behavioral: Mindful Awareness in Body-oriented Therapy Sponsors: University of Washington; National Center for Complementary and Integrative Health (NCCIH) Recruiting
Conditions: Cancer Survivor; Malignant Neoplasm Interventions: Behavioral: Health Education; Other: Physical Activity; Other: Text Message; Other: Web Site; Device: FitBit; Device: Actigraph; Other: Quality-of-Life Assessment; Other: Questionnaire Administration Sponsors: Fred Hutchinson Cancer Research Center; National Cancer Institute (NCI) Recruiting
Conditions: Spinal Cord Injuries; Spinal Cord Diseases; Central Nervous System Diseases; Nervous System Diseases; Trauma, Nervous System; Wounds and Injuries Interventions: Device: Transcutaneous spinal stimulation; Device: Epidural spinal stimulation Sponsors: University of Washington; U.S. National Science Foundation Recruiting
Condition: Metastatic Breast Cancer Interventions: Biological: huMNC2-CAR44 CAR T cells; Biological: huMNC2-CAR44 CAR T cells @ RP2D Sponsors: Minerva Biotechnologies Corporation; Fred Hutchinson Cancer Research Center Recruiting
Conditions: Pregnancy Related; Insomnia; Depression Interventions: Behavioral: OPTIMISM; Behavioral: Sleep Education Sponsors: University of Washington; National Institute of Nursing Research (NINR) Recruiting
Condition: Residual Paralysis, Post Anesthesia Intervention: Drug: Protocol for Management of Muscle Relaxation With Rocuronium Using Objective Monitoring and Reversal With Neostigmine or Sugammadex Sponsor: University of Washington Recruiting
Condition: Multiple Sclerosis Interventions: Behavioral: MBCT; Behavioral: CBT Sponsors: University of Washington; National Multiple Sclerosis Society Recruiting
Conditions: Colon Cancer; Rectal Cancer; Cancer Survivor; Colorectal Adenocarcinoma; Stage I Colorectal Cancer AJCC v8; Stage II Colorectal Cancer AJCC v8; Stage IIA Colorectal Cancer AJCC v8; Stage IIB Colorectal Cancer AJCC v8; Stage IIC Colorectal Cancer AJCC v8; Stage III Colorectal Cancer AJCC v8; Stage IIIA Colorectal Cancer AJCC v8; Stage IIIB Colorectal Cancer AJCC v8; Stage IIIC Colorectal Cancer AJCC v8 Interventions: Other: Dietary Intervention (resistant starch); Other: Dietary Intervention (regular starch); Other: Questionnaire Administration Sponsors: Fred Hutchinson Cancer Research Center; National Cancer Institute (NCI) Recruiting
Conditions: Healthy Subject; Breast Cancer Female Interventions: Behavioral: Exercise Intervention; Other: Resting; Other: Biomarker Analysis; Other: Questionnaire Administration Sponsors: Fred Hutchinson Cancer Research Center; National Cancer Institute (NCI) Recruiting
Condition: Hodgkin's Lymphoma Interventions: Biological: Pembrolizumab; Drug: Umbralisib Sponsors: University of Washington; National Cancer Institute (NCI) Recruiting
Condition: Other Skin Interventions: Biological: Autologous MCPyV-specific HLA-A02-restricted TCR-transduced CD4+ and CD8+ T-cells FH-MCVA2TCR; Drug: Avelumab; Radiation: Radiation Therapy; Biological: Pembrolizumab Sponsors: Fred Hutchinson Cancer Research Center; National Cancer Institute (NCI); Bluebird Biosciences Recruiting
Condition: Chronic Pain Interventions: Behavioral: Pain self-management training; Behavioral: video education, motivational interviewing; Drug: voluntary self-paced opioid taper; Drug: prescribing guidance for primary care provider; Other: usual care Sponsors: University of Washington; Kaiser Permanente Recruiting
Conditions: Breast Cancer Stage I; Breast Cancer Stage III; Breast Cancer Stage II; Breast Cancer Stage IIA; Breast Cancer Stage IIB; Breast Cancer Stage IIIA; Breast Cancer Stage IIIB; Breast Cancer Stage IIIc; Breast Cancer Intervention: Behavioral: Occupational Therapy Sponsor: University of Washington Recruiting
Condition: Chronic Pain Interventions: Behavioral: Cognitive Therapy (CT); Behavioral: Mindfulness Meditation (MM); Behavioral: Activation Skills (AS) Sponsors: University of Washington; Rush University; Medical University of South Carolina; The University of Queensland; National Center for Complementary and Integrative Health (NCCIH) Recruiting
Conditions: High Grade Ovarian Serous Adenocarcinoma; Stage III Ovarian Cancer AJCC v8; Stage IIIA Ovarian Cancer AJCC v8; Stage IIIA1 Ovarian Cancer AJCC v8; Stage IIIA2 Ovarian Cancer AJCC v8; Stage IIIB Ovarian Cancer AJCC v8; Stage IIIC Ovarian Cancer AJCC v8; Stage IV Ovarian Cancer AJCC v8; Stage IVA Ovarian Cancer AJCC v8; Stage IVB Ovarian Cancer AJCC v8 Interventions: Other: Biospecimen Collection; Other: Laboratory Biomarker Analysis; Other: Lavage; Other: Pap Smear Sponsors: University of Washington; National Cancer Institute (NCI); Minnesota Ovarian Cancer Alliance Recruiting
Condition: Smoking Cessation Interventions: Behavioral: Enhanced E-cigarette Coaching; Behavioral: Quitline treatment as usual Sponsors: Alere Wellbeing; University of Oklahoma; SRI International; H. Lee Moffitt Cancer Center and Research Institute Recruiting
Conditions: Pain Related to Cancer; Cancer of Head and Neck Interventions: Behavioral: Hypnosis; Behavioral: Mindfulness Sponsor: VA Puget Sound Health Care System Recruiting
Condition: Lower Extremity Amputation Interventions: Device: Torsionally adaptive prosthesis with 0:1 coupling ratio; Device: Torsionally adaptive prosthesis with 1:6 coupling ratio; Device: Torsionally adaptive prosthesis with 1:4 coupling ratio; Device: Torsionally adaptive prosthesis with 1:3 coupling ratio; Device: Torsionally adaptive prosthesis with 1:2 coupling ratio Sponsor: VA Office of Research and Development Recruiting
Conditions: Acute Myeloid Leukemia; High-Grade Myeloid Neoplasm; Blasts 10 Percent or More of Bone Marrow Nucleated Cells; Blasts 10 Percent or More of Peripheral Blood White Cells; High Grade Myeloid Neoplasm Interventions: Drug: Cladribine; Drug: Cytarabine; Drug: Gemtuzumab Ozogamicin; Biological: Granulocyte Colony-Stimulating Factor; Other: Laboratory Biomarker Analysis; Drug: Mitoxantrone Hydrochloride Sponsors: Fred Hutchinson Cancer Research Center; National Cancer Institute (NCI); Pfizer Recruiting
Conditions: Ankle Osteoarthritis; Healthy Ankles Interventions: Device: Rocker bottom shoe; Device: Ankle foot orthosis; Device: Standard walking shoe Sponsor: VA Office of Research and Development Recruiting
Conditions: Metastatic Head and Neck Squamous Cell Carcinoma; Recurrent Head and Neck Squamous Cell Carcinoma Interventions: Biological: Durvalumab; Other: Laboratory Biomarker Analysis; Radiation: Stereotactic Body Radiation Therapy; Biological: Tremelimumab; Procedure: Hypofractionated Image-Guided Radiation Therapy Sponsors: University of Washington; National Cancer Institute (NCI) Recruiting
Condition: Low Back Pain Interventions: Procedure: Lumbar medial branch nerve radiofrequency ablation (LRFA); Procedure: Simulated LRFA with targeted steroid injections; Behavioral: AcTIVE-CBT; Behavioral: TBSCE Sponsor: VA Office of Research and Development Recruiting
Conditions: B-Cell Non-Hodgkin Lymphoma; Follicular Lymphoma; Indolent Non-Hodgkin Lymphoma; Marginal Zone Lymphoma Interventions: Other: Laboratory Biomarker Analysis; Biological: Pembrolizumab Sponsors: University of Washington; National Cancer Institute (NCI) Recruiting
Condition: Ankle Osteoarthritis Interventions: Other: Dynamic 3D bone motion capture; Device: wedged insole Sponsor: VA Office of Research and Development Recruiting
Condition: Amputation Interventions: Device: Ottobock Kenevo/C-Leg; Device: Ottobock 3R60/3R62 Sponsors: University of Washington; United States Department of Defense; Otto Bock Healthcare Products GmbH Recruiting
Conditions: Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Follicular Lymphoma Interventions: Other: Laboratory Biomarker Analysis; Biological: Pembrolizumab; Biological: Rituximab Sponsors: University of Washington; National Cancer Institute (NCI) Recruiting
Conditions: Clear Cell Renal Cell Carcinoma; Stage III Renal Cell Cancer; Stage IV Renal Cell Cancer Interventions: Biological: Aldesleukin; Biological: Pembrolizumab Sponsors: University of Washington; National Cancer Institute (NCI) Recruiting
Conditions: Metastatic Leiomyosarcoma; Metastatic Liposarcoma; Unresectable Leiomyosarcoma; Unresectable Liposarcoma Interventions: Drug: Avelumab; Drug: Trabectedin Sponsors: Fred Hutchinson Cancer Research Center; National Cancer Institute (NCI) Recruiting
Conditions: Gulf War; Fatigue; Pain; Depression Interventions: Behavioral: Mindfulness-Based Stress Reduction; Behavioral: Chronic Disease Self-Management Program Sponsor: VA Office of Research and Development Recruiting
Conditions: High Grade Anal Canal Squamous Intraepithelial Neoplasia; Vulvar High Grade Squamous Intraepithelial Lesion Interventions: Other: Laboratory Biomarker Analysis; Other: Placebo; Other: Questionnaire Administration; Biological: Recombinant Human Papillomavirus Nonavalent Vaccine Sponsors: Fred Hutchinson Cancer Research Center; National Cancer Institute (NCI) Recruiting
Conditions: Anemia; Myelodysplastic Syndrome Interventions: Drug: Deferasirox; Other: Laboratory Biomarker Analysis Sponsors: Fred Hutchinson Cancer Research Center; National Cancer Institute (NCI); Novartis Pharmaceuticals Recruiting
Conditions: Castration Levels of Testosterone; Castration-Resistant Prostate Carcinoma; Metastatic Prostate Carcinoma; Prostate Carcinoma Metastatic in the Bone; PSA Progression; Stage IV Prostate Cancer Interventions: Drug: Carboplatin; Drug: Docetaxel; Other: Laboratory Biomarker Analysis Sponsors: University of Washington; National Cancer Institute (NCI) Recruiting
Conditions: Castration Levels of Testosterone; Castration-Resistant Prostate Carcinoma; Metastatic Prostate Carcinoma; Prostate Carcinoma Metastatic in the Bone; PSA Level Greater Than or Equal to Two; PSA Progression; Stage IV Prostate Cancer AJCC v7 Interventions: Drug: Carboplatin; Drug: Docetaxel; Other: Laboratory Biomarker Analysis; Drug: Sirolimus Sponsors: University of Washington; National Cancer Institute (NCI) Recruiting
Conditions: Prostate Cancer; Prostatic Cancer; Prostate Neoplasms; Prostatic Neoplasms; Cancer of the Prostate Intervention: Radiation: CyberKnife Stereotactic Radiosurgery Sponsor: Swedish Medical Center Recruiting
Conditions: Posttraumatic Headache; Combat Disorders; Post Concussion Syndrome; Headache; Mild Traumatic Brain Injury; Posttraumatic Migraine Interventions: Drug: prazosin hydrochloride; Drug: placebo Sponsor: VA Office of Research and Development Recruiting
Conditions: HER2/Neu Negative; Recurrent Breast Carcinoma; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer; Stage III Breast Cancer Interventions: Biological: CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine; Other: Laboratory Biomarker Analysis Sponsors: University of Washington; United States Department of Defense; National Cancer Institute (NCI) Recruiting
Conditions: Brain Injuries, Traumatic; Chronic Pain; Post-Traumatic Headache Intervention: Behavioral: Collaborative Care Sponsors: University of Washington; National Institute on Disability, Independent Living, and Rehabilitation Research Recruiting
Conditions: Ankle Osteoarthritis; Flat Foot or Pes Planus Intervention: Device: custom orthoses with varying degrees of hindfoot posting Sponsors: VA Office of Research and Development; University of Washington Recruiting
Conditions: Healthy Control; Localized Urothelial Carcinoma of the Renal Pelvis and Ureter; Metastatic Malignant Neoplasm in the Bone; Metastatic Malignant Neoplasm in the Soft Tissues; Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter; Recurrent Bladder Carcinoma; Recurrent Prostate Carcinoma; Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter; Stage IV Bladder Cancer; Stage IV Bladder Urothelial Carcinoma; Stage IV Prostate Cancer Interventions: Other: Cytology Specimen Collection Procedure; Other: Laboratory Biomarker Analysis Sponsors: University of Washington; National Cancer Institute (NCI) Recruiting
Conditions: Schizophrenia; Bipolar Disorder; Major Depressive Disorder; Alcohol Dependence Interventions: Behavioral: Usual CM; Behavioral: High-Magnitude CM; Behavioral: Shaping CM Sponsors: Washington State University; National Institute on Alcohol Abuse and Alcoholism (NIAAA) Recruiting
Conditions: Viral Upper Respiratory Tract Infection; Allogeneic Bone Marrow Transplantation Recipient Interventions: Drug: Nozin; Other: Best Practice Sponsors: Fred Hutchinson Cancer Research Center; National Cancer Institute (NCI); Global Life Technologies Corp. Recruiting
Conditions: Bladder Cancer; Cancer of the Bladder, Recurrent; Non-muscle Invasive Bladder Cancer Intervention: Sponsors: University of Washington; Patient-Centered Outcomes Research Institute Recruiting
Condition: Unspecified Adult Solid Tumor, Protocol Specific Intervention: Biological: TR1801-ADC Sponsors: Tanabe Research Laboratories USA Inc; Open Innovation Partners Recruiting
Condition: Multiple Sclerosis Interventions: Behavioral: Telephone-based Cognitive Behavioral Therapy; Drug: Modafinil Sponsors: University of Michigan; University of Washington; Patient-Centered Outcomes Research Institute; National Multiple Sclerosis Society Recruiting
Condition: Pancreatic Cancer Interventions: Drug: Nivolumab + Cabiralizumab; Radiation: Stereotactic Body Radiotherapy (SBRT) Sponsor: NYU Langone Health Recruiting
Conditions: HIV Positive; Alcohol Use Interventions: Behavioral: Computerized Brief Intervention (CBI); Behavioral: CBT4CBT; Drug: Recommendation and Counseling for Alcohol Pharmacotherapy Sponsor: University of Alabama at Birmingham Recruiting
Condition: Major Depression Interventions: Behavioral: Band Together; Other: Control Mobile 3D video game Sponsors: University of Washington; Weill Medical College of Cornell University; University of California, San Francisco Recruiting
Conditions: Prostate Adenocarcinoma; Testosterone Greater Than or Equal to 150 ng/dL Interventions: Drug: Apalutamide; Other: Laboratory Biomarker Analysis; Other: Quality-of-Life Assessment; Other: Questionnaire Administration Sponsors: University of Washington; Janssen Scientific Affairs, LLC; National Cancer Institute (NCI) Recruiting
Conditions: Heart Failure; Pulmonary Disease, Chronic Obstructive; Emphysema; Pulmonary Fibrosis, Interstitial Lung Disease Intervention: Behavioral: ADAPT Intervention Sponsor: VA Office of Research and Development Recruiting
Conditions: Advanced Malignant Solid Neoplasm; Bile Duct Carcinoma; Recurrent Malignant Solid Neoplasm; Recurrent Pancreatic Carcinoma; Stage III Pancreatic Cancer AJCC v6 and v7; Stage IVA Pancreatic Cancer; Stage IVB Pancreatic Cancer Interventions: Drug: Afatinib Dimaleate; Drug: Capecitabine; Other: Laboratory Biomarker Analysis Sponsors: University of Washington; National Cancer Institute (NCI) Recruiting
Conditions: Chronic Disease; Neoplasm Metastasis; Lung Neoplasm; Pulmonary Disease, Chronic Obstructive; Heart Failure, Congestive; Liver Cirrhosis; Kidney Failure, Chronic; Multiple Organ Failure; Health Care Quality, Access, and Evaluation; Intensive Care Units; Palliative Care, Health Services; Palliative Care, Patient Care; Lung Diseases, Interstitial Intervention: Behavioral: Facilitator-Based Intervention Sponsor: University of Washington Recruiting
Conditions: Dietary Habits; Health Behavior; Eating Behavior Interventions: Behavioral: Behavioral Gardening Exposure; Behavioral: Healthy Eating and Gardening Curriculum; Behavioral: Family Workshops Sponsor: Fred Hutchinson Cancer Research Center Recruiting
Conditions: Acute Myeloid Leukemia; CD33 Positive; Minimal Residual Disease Interventions: Drug: Gemtuzumab Ozogamicin; Other: Quality-of-Life Assessment Sponsors: University of Washington; National Cancer Institute (NCI) Recruiting
Condition: Prostate Adenocarcinoma Interventions: Procedure: Evaluation; Other: Quality-of-Life Assessment Sponsors: University of Washington; National Cancer Institute (NCI) Recruiting
Conditions: Chronic Graft Versus Host Disease; Hematopoietic Cell Transplantation Recipient Interventions: Biological: Immunosuppressive Therapy; Other: Survey Administration Sponsors: Fred Hutchinson Cancer Research Center; National Cancer Institute (NCI) Recruiting
Conditions: Cardiovascular Disease (CVD); Hypertension; Hyperlipemia; Obesity Intervention: Other: Community-based peer health coach intervention Sponsor: VA Office of Research and Development Recruiting
Conditions: Parkinson Disease; GBA Gene Mutation; Gaucher Disease Interventions: Diagnostic Test: PET scan; Diagnostic Test: neuroQWERTY Sponsors: Pacific Parkinson's Research Centre; University of British Columbia; University of Washington; Oregon Health and Science University; Simon Fraser University; Michael J. Fox Foundation for Parkinson's Research; Silverstein Foundation; Weston Brain Institute Recruiting
Conditions: Chronic Graft Versus Host Disease; Fasciitis; Sclerosis Intervention: Drug: Glasdegib Sponsors: Fred Hutchinson Cancer Research Center; National Cancer Institute (NCI); Pfizer Recruiting
Conditions: Parkinson Disease; Dyskinesia, Drug-Induced Intervention: Drug: Intravenous Infusion Sponsors: VA Office of Research and Development; Oregon Health and Science University Recruiting
Condition: Cardiorespiratory Failure Intervention: Behavioral: Mobile mindfulness-based training Sponsors: Duke University; University of Washington; University of Colorado, Denver; National Center for Complementary and Integrative Health (NCCIH) Recruiting
Condition: Colorectal Adenoma Interventions: Drug: Linaclotide; Other: Placebo Sponsors: Sidney Kimmel Cancer Center at Thomas Jefferson University; United States Department of Defense Recruiting
Condition: Amputation Interventions: Device: Prosthetic Foot Emulator; Device: Commercially available prosthetic feet Sponsors: Seattle Institute for Biomedical and Clinical Research; VA Puget Sound Health Care System; Minneapolis Veterans Affairs Medical Center; Brooke Army Medical Center; Stanford University; University of Washington Recruiting
Condition: Stem Cell Transplant Interventions: Other: Palliative Care Intervention; Other: Standard Transplant Care Sponsors: Massachusetts General Hospital; National Institutes of Health (NIH); National Cancer Institute (NCI) Recruiting
Conditions: Smoking Reduction; Tobacco Use; Tobacco Smoking; Tomography; Lung Diseases; Lung Neoplasms Interventions: Behavioral: Unsigned note to provider about cessation medication prescription; Behavioral: Proactive Telephone Counseling from VA Quitline Sponsors: VA Office of Research and Development; Fred Hutchinson Cancer Research Center Recruiting
Conditions: Acute Pain; Low Back Pain, Mechanical Interventions: Behavioral: Supported-Self Management (SSM); Other: Spinal Manipulation Therapy (SMT); Combination Product: SMT + SSM; Drug: Standard Medical Care (SMC) Sponsors: University of Minnesota; University of Pittsburgh; University of Washington; University of North Texas Health Science Center; Oregon Health and Science University; Duke University Recruiting
Condition: Myelodysplastic Syndromes Interventions: Drug: CPX-351; Procedure: Research skin biopsy; Procedure: Research blood draw; Procedure: Research bone marrow aspirate Sponsors: Washington University School of Medicine; Jazz Pharmaceuticals Recruiting
Condition: Soft Tissue Sarcoma Adult Interventions: Drug: Multiple drug microinjection; Device: CIVO device Sponsors: Presage Biosciences; Fred Hutchinson Cancer Research Center; University of Washington; Northwell Health; Oregon Health and Science University Recruiting
Condition: Alpers Huttenlocher Syndrome Intervention: Sponsors: Columbia University; Seattle Children's Hospital; National Institute of Neurological Disorders and Stroke (NINDS) Recruiting
Conditions: Hormone-Resistant Prostate Cancer; Metastatic Prostate Carcinoma; Recurrent Prostate Carcinoma; Stage IV Prostate Cancer Interventions: Drug: Carboplatin; Drug: Docetaxel Sponsors: Seattle Institute for Biomedical and Clinical Research; Prostate Cancer Foundation; VA Puget Sound Health Care System Recruiting
Condition: Ureteral Stones Interventions: Procedure: Ureteral stone removal; Procedure: Asymptomatic kidney stones and ureteral stone removed Sponsors: Indiana Kidney Stone Institute; University of Washington Medical Center Department of Urology (Seattle, WA); VA Puget Sound Health Care System Recruiting
Conditions: Chronic Myelomonocytic Leukemia; de Novo Myelodysplastic Syndrome; Myelodysplastic Syndrome; Secondary Myelodysplastic Syndrome Interventions: Drug: Azacitidine; Drug: Decitabine; Other: Quality-of-Life Assessment Sponsors: Fred Hutchinson Cancer Research Center; National Cancer Institute (NCI) Recruiting
Conditions: Severe Life-limiting COPD; Severe Life-limiting Heart Failure; Severe Life-limiting Cirrhosis; Severe Life-limiting Malignancy; Severe Functional Impairment Interventions: Behavioral: Informed Assent Discussion; Behavioral: Usual Care with Attention Control Sponsors: University of Vermont; University of Washington; Medical University of South Carolina; University of California, San Francisco Recruiting
Conditions: Congenital Central Hypoventilation Syndrome; Congenital Central Hypoventilation; CCHS; CCHS With Hirschsprung Disease; CCHS With Neural Crest Tumor; CCHS With Neuroblastoma Intervention: Other: NIH Toolbox Cognition Battery Sponsors: Debra Weese-Mayer; Ann & Robert H Lurie Children's Hospital of Chicago; Seattle Children's Hospital; Children's Hospital Los Angeles Recruiting
Conditions: Methicillin-Resistant Staphylococcus Aureus; Cystic Fibrosis Intervention: Other: Intervention N/A. Observational study Sponsor: University of North Carolina, Chapel Hill Recruiting
Condition: Opioid Use Disorder Interventions: Other: Standard Dissemination Practice; Other: Implementation Facilitation (IF) Sponsors: Yale University; National Institute on Drug Abuse (NIDA); The Emmes Company, LLC Recruiting
Conditions: Estrogen Receptor-positive Breast Cancer; HER2/Neu Negative; Stage IV Breast Cancer AJCC v6 and v7 Interventions: Drug: Palbociclib; Drug: Letrozole; Drug: Fulvestrant; Other: Questionnaire Administration; Other: Quality-of-Life Assessment Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI) Recruiting
Condition: Lymphoma, Mantle Cell Interventions: Drug: Acalabrutinib in combination with bendamustine and rituximab; Drug: Placebo in combination with bendamustine and rituximab Sponsor: Acerta Pharma BV Recruiting
Condition: Cytomegalovirus Infection Interventions: Device: DBS Self-Collection Kit; Other: Standard Control Strategy Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Recruiting
Condition: Brain Injuries, Traumatic Interventions: Other: ICP + PbtO2 guided management strategy; Other: ICP guided management strategy Sponsors: University of Michigan; National Institute of Neurological Disorders and Stroke (NINDS); University of Washington; University of Pennsylvania; University of Pittsburgh; Medical University of South Carolina Recruiting
Conditions: Anal Squamous Cell Carcinoma; HIV Infection; Stage 0 Anal Canal Cancer; Stage I Anal Canal Cancer Intervention: Procedure: Therapeutic Conventional Surgery Sponsors: AIDS Malignancy Consortium; National Cancer Institute (NCI); The Emmes Company, LLC; AIDS and Cancer Specimen Resource; University of Arkansas Recruiting
Conditions: Pharmacies; Opioid Use; Patient Safety Intervention: Behavioral: MOON+ Sponsors: Boston Medical Center; Comagine Health; Oregon Health and Science University; University of Rhode Island; University of Washington; National Institute on Drug Abuse (NIDA) Recruiting
Condition: AIDS-Related Primary Effusion Lymphoma Interventions: Genetic: Laboratory Biomarker Analysis; Other: Medical Chart Review Sponsors: AIDS Malignancy Consortium; National Cancer Institute (NCI); University of California, San Diego; University of Arkansas Recruiting
Conditions: Cardiotoxicity; HER2/Neu Positive; Metastatic Malignant Neoplasm in the Brain; Recurrent Breast Carcinoma; Stage IV Breast Cancer AJCC v6 and v7 Interventions: Drug: Carvedilol; Other: Laboratory Biomarker Analysis; Other: Patient Observation Sponsors: Southwest Oncology Group; National Cancer Institute (NCI) Recruiting
Condition: Node Positive HER2 Negative Breast Cancer Interventions: Other: Placebo; Drug: Aspirin Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI); United States Department of Defense; Bayer; Canadian Cancer Trials Group Recruiting
Condition: Breast Carcinoma Interventions: Other: Health Education Program; Other: Weight Loss Intervention Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI); Division of Cancer Control; NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP); Canadian Cancer Trials Group Recruiting
Conditions: Anatomic Stage IV Breast Cancer AJCC v8; Estrogen Receptor Positive; HER2/Neu Negative; Progesterone Receptor Positive; Prognostic Stage IV Breast Cancer AJCC v8; Elevated CA15-3 or CEA or CA27-29 Interventions: Other: Usual care disease monitoring; Other: Serum Tumor Marker directed disease monitoring; Other: Quality-of-Life Assessment; Other: Anxiety Questionnaire Administration Sponsors: Southwest Oncology Group; National Cancer Institute (NCI) Recruiting
Conditions: Ductal Breast Carcinoma; Invasive Breast Carcinoma; Lobular Breast Carcinoma; Medullary Breast Carcinoma; Stage II Breast Cancer; Stage IIA Breast Cancer; Stage IIB Breast Cancer; Stage IIIA Breast Cancer; Tubular Breast Carcinoma Interventions: Radiation: Radiation Therapy; Other: Questionnaire Administration; Other: Quality-of-Life Assessment; Other: Laboratory Biomarker Analysis; Radiation: Hypofractionated Radiation Therapy Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI); Canadian Cancer Trials Group Recruiting
Conditions: Invasive Breast Carcinoma; Stage 0 Breast Cancer AJCC v6 and v7; Stage I Breast Cancer AJCC v7; Stage IA Breast Cancer AJCC v7; Stage IB Breast Cancer AJCC v7; Stage II Breast Cancer AJCC v6 and v7; Stage IIA Breast Cancer AJCC v6 and v7; Stage IIB Breast Cancer AJCC v6 and v7; Stage III Breast Cancer AJCC v7; Stage IIIA Breast Cancer AJCC v7; Stage IIIB Breast Cancer AJCC v7; Stage IIIC Breast Cancer AJCC v7; Triple-Negative Breast Carcinoma Interventions: Other: Laboratory Biomarker Analysis; Other: Patient Observation; Biological: Pembrolizumab; Other: Quality-of-Life Assessment; Other: Questionnaire Administration; Radiation: Radiation Therapy Sponsor: National Cancer Institute (NCI) Recruiting
Conditions: Anatomic Stage I Breast Cancer AJCC v8; Anatomic Stage IA Breast Cancer AJCC v8; Anatomic Stage IB Breast Cancer AJCC v8; Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage IIA Breast Cancer AJCC v8; Anatomic Stage IIB Breast Cancer AJCC v8; Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IIIA Breast Cancer AJCC v8; Anatomic Stage IIIB Breast Cancer AJCC v8; Anatomic Stage IIIC Breast Cancer AJCC v8; Invasive Breast Carcinoma; Prognostic Stage I Breast Cancer AJCC v8; Prognostic Stage IA Breast Cancer AJCC v8; Prognostic Stage IB Breast Cancer AJCC v8; Prognostic Stage II Breast Cancer AJCC v8; Prognostic Stage IIA Breast Cancer AJCC v8; Prognostic Stage IIB Breast Cancer AJCC v8; Prognostic Stage III Breast Cancer AJCC v8; Prognostic Stage IIIA Breast Cancer AJCC v8; Prognostic Stage IIIB Breast Cancer AJCC v8; Prognostic Stage IIIC Breast Cancer AJCC v8 Interventions: Drug: Docetaxel; Drug: Paclitaxel; Other: Quality-of-Life Assessment; Other: Questionnaire Administration Sponsors: ECOG-ACRIN Cancer Research Group; National Cancer Institute (NCI) Recruiting
Conditions: Diffuse Large B-Cell Lymphoma; Double-Expressor Lymphoma; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; Neoplastic Cells With Double Expression of MYC and BCL2 Proteins Present Interventions: Drug: Cyclophosphamide; Drug: Doxorubicin; Drug: Doxorubicin Hydrochloride; Drug: Etoposide; Drug: Prednisone; Biological: Rituximab; Drug: Venetoclax; Drug: Vincristine; Drug: Vincristine Sulfate Sponsor: National Cancer Institute (NCI) Recruiting
Conditions: Skin Squamous Cell Carcinoma; Metastatic Skin Cancer Interventions: Drug: Avelumab; Drug: Cetuximab Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI) Recruiting
Condition: Multiple Myeloma in Relapse Interventions: Drug: pomalidomide; Drug: ixazomib; Drug: dexamethasone Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI); Celgene Corporation; Millennium Pharmaceuticals, Inc. Recruiting
Condition: Appendicitis Interventions: Drug: Cefoxitin, Ertapenem, Moxifloxacin, Tigecycline, Ticarcillin-Clavulanic Acid; Metronidazole plus Cefazolin, Cefuroxime, Ceftriaxone, Cefotaxime, Ciprofloxacin, or Levofloxacin; Procedure: Appendectomy Sponsors: University of Washington; Patient-Centered Outcomes Research Institute Recruiting
Conditions: Stage III Renal Cell Cancer AJCC v7; Stage IV Renal Cell Cancer AJCC v7; Type 1 Papillary Renal Cell Carcinoma; Type 2 Papillary Renal Cell Carcinoma; Unresectable Renal Cell Carcinoma Interventions: Drug: Cabozantinib; Drug: Cabozantinib S-malate; Drug: Crizotinib; Drug: Savolitinib; Drug: Sunitinib; Drug: Sunitinib Malate Sponsors: National Cancer Institute (NCI); Canadian Cancer Trials Group Recruiting